Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The SMARTT e-Patch is an advanced electronic transdermal drug delivery platform developed by Rhenovia Pharma. It is designed as a programmable system capable of controlled, chronobiological administration of up to seven different medicinal products simultaneously. The technology integrates several innovations, including an ultra-slim battery, a flexible printed electronic circuit, and UV-LED ink that interacts with novel photolabile ligands within transdermal nanovectors to trigger drug release. This system allows physicians to program specific dosage schedules remotely, aiming to improve bioavailability and efficacy while minimizing side effects. Although initially developed for central nervous system disorders such as Alzheimer's disease, the platform is intended for a broad range of chronic conditions requiring complex medication regimens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SMARTT e-Patch.